Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Advanced Cancer × Sunitinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Renal Cell 60 Neoplasm Metastasis 23 Kidney Neoplasms 23 Neoplasms 13 Breast Neoplasms 13 Prostatic Neoplasms 11 Urinary Bladder Neoplasms 9 Melanoma 8 Glioblastoma 8 Sarcoma 7 Gastrointestinal Stromal Tumors 7 Carcinoma, Non-Small-Cell Lung 7 Brain Neoplasms 6 Ovarian Neoplasms 5 Esophageal Neoplasms 5 Colorectal Neoplasms 5 Thyroid Neoplasms 4 Solid Tumors 4 Recurrence 4 Pancreatic Neoplasms 4 Osteosarcoma 4 Lung Neoplasms 4 Liver Neoplasms 4 Leukemia, Myeloid, Acute 4 Carcinoma, Hepatocellular 4 Adenocarcinoma 4 Uveal Melanoma 3 Stomach Neoplasms 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Neoplasms, Germ Cell and Embryonal 3

Interventions

Surveys and Questionnaires 7 Bevacizumab 5 temsirolimus 4 Standard of Care 4 Sirolimus 4 Interviews as Topic 4 Vorinostat 2 Paclitaxel 2 Magnetic Resonance Spectroscopy 2 Everolimus 2 Erlotinib Hydrochloride 2 Cetuximab 2 zaleplon 1 vistusertib 1 tilsotolimod 1 pazopanib 1 olaparib 1 liposomal doxorubicin 1 capivasertib 1 apatinib 1 Videotape Recording 1 Vemurafenib 1 Valproic Acid 1 Trastuzumab 1 Topotecan 1 Temozolomide 1 Sunitinib 1 Sorafenib 1 Rehabilitation 1 Referral and Consultation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00543504 2020-06-30

Bevacizumab in Multiple Phase I Combinations

M.D. Anderson Cancer Center

Phase 1 Completed

Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡